NCT06748339

Brief Summary

Colorectal cancer (CRC) is reported to be the third leading cause of cancer deaths worldwide, and its prevalence is steadily rising in developing countries. It can be considered a marker of socioeconomic development and a marker of significant changes in food habits and lifestyle. In Egypt, CRC represents the seventh most common cancer. It is the third most reported cancer in males and the fifth most common cancer in females. microbiome dysbiosis may be involved in the pathogensis and thus pose a therapeutic target

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
18

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Jan 2024

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2024

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 17, 2024

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

December 17, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 17, 2024

Completed
10 days until next milestone

First Posted

Study publicly available on registry

December 27, 2024

Completed
Last Updated

December 27, 2024

Status Verified

December 1, 2024

Enrollment Period

9 months

First QC Date

December 17, 2024

Last Update Submit

December 21, 2024

Conditions

Keywords

CRCmicrobiome

Outcome Measures

Primary Outcomes (2)

  • The effect of food and lifestyle on microbiome

    correlation between food and lifestyle with microbiome profiles

    "through study completion, an average of 1 year"

  • microbiome profile and CRC pathogensis

    correlation between microbiome profile and CRC pathogensis

    "through study completion, an average of 1 year"

Study Arms (2)

contol group

6 healthy participants

Other: no intervention

CRC group

12 newly diagnosed CRC patients

Other: no intervention

Interventions

no intervention

CRC groupcontol group

Eligibility Criteria

Age40 Years - 80 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

12 newly diagnosed CRC patiens vs 6 healthy voulnteers

You may qualify if:

  • Age of 40 years to 80 years
  • Patients with a newly diagnosed CRC

You may not qualify if:

  • Patients with previously known CRC
  • Pregnancy or Lactation
  • Abdominal surgery within/up to 6 months prior to sample collection
  • Antibiotics, corticosteroids, or probiotics up to three months prior to sample collection
  • History of other types of cancer
  • Subjects on a special diet
  • Diabetes, liver, or kidney diseases
  • CRC patients who used enema or underwent colonoscopy up to one week before sample collection.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

cairo university Hopitals (elKasr ELieny )

Cairo, Egypt

Location

Related Publications (1)

  • Baas FS, Brusselaers N, Nagtegaal ID, Engstrand L, Boleij A. Navigating beyond associations: Opportunities to establish causal relationships between the gut microbiome and colorectal carcinogenesis. Cell Host Microbe. 2024 Aug 14;32(8):1235-1247. doi: 10.1016/j.chom.2024.07.008.

    PMID: 39146796BACKGROUND

Related Links

Biospecimen

Retention: SAMPLES WITH DNA

DNA extracted from fecal samples

MeSH Terms

Conditions

Colorectal Neoplasms

Condition Hierarchy (Ancestors)

Intestinal NeoplasmsGastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasmsDigestive System DiseasesGastrointestinal DiseasesColonic DiseasesIntestinal DiseasesRectal Diseases

Study Officials

  • sara M eladwy

    Heliopolis University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
lecturer

Study Record Dates

First Submitted

December 17, 2024

First Posted

December 27, 2024

Study Start

January 1, 2024

Primary Completion

September 17, 2024

Study Completion

December 17, 2024

Last Updated

December 27, 2024

Record last verified: 2024-12

Data Sharing

IPD Sharing
Will not share

Patients' information will be assigned codes. no need to reveal it

Locations